- Exchange: Copenhagen
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for H Lundbeck A/S (LUN)
| Open: | 125.000 | Day's Range: | 123.500 - 127.700 | Volume: | 481,404 | Bid: | 126.100 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 124.200 | 52wk Range: | 98.150 - 140.200 | 1-Yr Rtn: | -1.02% | Ask: | 126.500 |
Key Statistics for LUN
| Current P/E Ratio (ttm) | 12.5814 |
|---|---|
| Estimated P/E (12/2012) | 14.0337 |
| Earnings Per Share (DKK) (ttm) | 10.0545 |
| Est. EPS (DKK) (12/2012) | 9.0140 |
| Est. PEG Ratio | - |
| Market Cap (M DKK) | 24,811.19 |
| Shares Outstanding (M) | 196.14 |
| Enterprise Value (M DKK) (ttm) | 22,734.19 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 1.9668 |
| Price/Sale (ttm) | 1.5819 |
| Dividend Indicated Gross Yield | 2.7589 |
| Next Earnings Announcement | 08/08/2012 |
More LUN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for LUN
- Operating
- Investing
- Financing (M/DKK)
Company Profile & Key Executives for LUN
H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.
| Ulf WiinbergPresident/CEO | Anders GotzscheExec VP/CFO |
| Anders Gersel PedersenExec VP:Research & Dev | Marie-Laure PochonExec VP:Commercial Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page